Kaiser Health News

Programs substantially cut the risk of dying from another cardiac problem, improve quality of life and lower costs; less than one-third of patients whose conditions qualify for the rehab actually participate.

"Adverse drug events" drive up health care costs annually by about $3.5 billion, add about three days to the average stay, DHHS says.

Patient advocates have argued that follow-up colonoscopies should be provided without cost sharing by patients; awareness can help patients prepare for facility fees.

Legislation also would require the nation's first minimum nurse-to patient staffing ratios in observation care units.

Massive project is the culmination of a long-running effort at Case to train different types of health professionals how to work together.

Report describes steps states can take to address a number of drug-coverage issues in the commercial insurance market.

SPOT facility, professionals offer safe place to ride out high, seek new start for treatment.

Physicians' concern is that the new payment system will put doctors in solo or small practices at high risk of incurring payment penalties and will push thousands into larger practices and alternative payment organizations.

State officials do not quibble about where Georgia ranks and note that the numbers have risen since 2010. And they vow to do something about it.

The "most important factor" that drives prescription drug prices higher in the United States than anywhere else in the world is the existence of government-protected "monopoly" rights for drug manufacturers, researchers at Harvard Medical School reported today.